Establishment Labs Holdings Inc. (ESTA)
NASDAQ: ESTAHealth CareIndustrial SpecialtiesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
ESTA stock chart
Technical analysisKey statistics
All statistics- Market cap
- $2.06B
- EPS (TTM)
- -$1.27
- Dividend yield
- None
- 52-week range
- 53.16 – 97.59
- Day range
- 65.00 – 71.07
- Volume / Avg
- 464.24K / 411.24K
- Beta
- —
- Shares outstanding
- 29.82M
52-week range
ESTA stock today
Shares of Establishment Labs (ESTA) finished lower on Nov 20 at $69.14, a drop of 0.68% or $0.47 per share, versus the S&P 500's 3.70% decline. Shares are 29.2% below their 52-week high of $97.59, set on Aug 3, 2026 and 30.1% above the 52-week low of $53.16, in the middle of the past year's range. ESTA is down 5.1% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 1.6%.
Establishment Labs has posted a net loss over the last twelve months (EPS of -$1.27), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Establishment Labs
Company profileEstablishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for breast aesthetic and reconstructive plastic surgeries in Europe, the Middle East, Africa, Latin America, Asia, and the United States. The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders.
- Sector
- Health Care
- Industry
- Industrial Specialties
- CEO
- Mr. Fillipo Peter Caldini
- Headquarters
- Austin, TX
- Employees
- 1,004
- IPO year
- 2018
- Website
- establishmentlabs.com
Financial highlights
Full financialsIn fiscal 2025, Establishment Labs generated $211.1 million in revenue, up 27.1% from fiscal 2024, its 5th consecutive year of revenue growth. Establishment Labs reported a net loss of $51.1 million, compared with a loss of $84.6 million a year earlier. Gross margin was 69.3% (up from 66.0%) and operating margin -18.5%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $211.08M | $166.03M | $165.15M | $161.70M | $126.68M |
| Growth | +27.14% | +0.53% | +2.13% | +27.64% | +49.61% |
| Net income | $-51.06M | $-84.60M | $-78.50M | $-75.21M | $-41.14M |
| EPS (diluted) | $-1.72 | $-3.00 | $-3.07 | $-3.08 | $-1.72 |
Analyst forecast
ForecastConsensus (10 analysts)
strong_buy
Avg. price target
$98.00+41.74%
- Strong buy 2
- Buy 8
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Oct 29, 2026
- EPS actual vs est.
- $-0.38 vs $-0.27
- Surprise
- -40.74%
ESTA news
All ESTA news- Establishment Labs (ESTA) Q3 2026 Earnings Call TranscriptNasdaqESTA, BRK.A
- Establishment Labs projects 25% revenue growth in 2027 as it raises 2026 revenue guidance to more than $274MSeeking Alpha
- Establishment Labs® Reports Third Quarter 2026 Financial ResultsBusiness Wire
- Establishment Labs Q3 2026 Earnings PreviewSeeking Alpha
- Notable Monday Option Activity: ACTG, ESTA, AANasdaqACTG, ESTA, AA
- Establishment Labs Holdings Inc. (ESTA) Expected to Beat Earnings Estimates: Should You Buy?NasdaqESTA, HCA
- Establishment Labs® to Announce Third Quarter 2026 Financial Results on October 29Business Wire
- Establishment Labs a new Buy at Stifel on end-market prospectsSeeking Alpha
Establishment Labs peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| DSGRDistribution Solutions Group Inc. | 35.00 | -0.09% | $1.62B | vs ESTA |
| ENOVEnovis Corporation | 25.47 | -2.90% | $1.47B | vs ESTA |
| TRSTriMas Corporation | 36.77 | -2.52% | $1.30B | vs ESTA |
| CDRECadre Holdings Inc. | 29.45 | -3.63% | $1.26B | vs ESTA |
| XPELXPEL Inc. | 38.12 | +1.36% | $1.05B | vs ESTA |
| FOILLondian Wason New Energy Tech Inc. ADR | 12.30 | -11.95% | $969.05M | vs ESTA |
| WLFCWillis Lease Finance Corporation | 41.96 | -2.31% | $957.23M | vs ESTA |
| ADSEADS-TEC ENERGY PLC | 9.78 | +3.82% | $735.32M | vs ESTA |
Indexes, lists and sector
Establishment Labs stock FAQ
What is Establishment Labs's stock price today?
ESTA last traded at $69.14 as of Nov 20, 4:00 PM EST, down 0.68% on the day. Prices are delayed at least 15 minutes.
Who is Establishment Labs's CEO?
Mr. Fillipo Peter Caldini is the chief executive officer of Establishment Labs Holdings Inc., which has about 1,004 employees.
What is the ESTA 52-week high?
The 52-week high for ESTA is $97.59 and the 52-week low is $53.16. The stock is currently 29.2% below its high.